Abstract
The labeling of cells with fluorescent nanoparticles is promising for various biomedicalapplications. The objective of this study is to evaluate the biocompatibility and themechanism of the cellular uptake of fluorescent nanodiamonds (FNDs) in cancer cells(HeLa) and pre-adipocytes (3T3-L1). With flow cytometry and the use of a battery ofmetabolic and cytoskeletal inhibitors, we found that the mechanism of the FND uptake inboth cells is by energy-dependent clathrin-mediated endocytosis. In addition, the surfacecharge of FND influences its cellular uptake, as the uptake of poly-L-lysine-coated FNDs isbetter than that of oxidative-acid-purified FNDs at the same concentration in regularmedium with or without serum. We also confirm that the proliferative potential ofFND-treated and untreated cells does not exhibit any significant differences when measuredat bulk cultures, and more stringently at clonal cell density. Further biocompatibilitystudies indicate that the in vitro differentiation of 3T3-L1 pre-adipocytes and 489-2osteoprogenitors is not affected by the FND treatment. Our results show that FNDs arebiocompatible and ideal candidates for potential applications in human stem cell research.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
